Term ends Oct 28, 2031 · High confidence
20-year base term ends Nov 4, 2031
Held by Novartis AG
Filed Dec 8, 2021 as application 17/545,894 · Granted Nov 11, 2025
Base term plus 756 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2011
2031
Clock starts
Nov 4, 2011
Nov 4, 2011
Term ends
Oct 28, 2031
Oct 28, 2031
Granted
Nov 11, 2025
Nov 11, 2025
base term
after the term ends
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
756
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,363,307, US 11,534,491, US 9,744,234.
0 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
12
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 756 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 1 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 4, 2011, when application PCT/EP2011/069476, the earliest non-provisional in its chain, was filed (this one was filed Dec 8, 2021) | Nov 4, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +756 days, USPTO patent term adjustment record | Nov 29, 2033 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,363,307, US 11,534,491, US 9,744,234) | capped to Oct 28, 2031 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 1 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 28, 2031 | High confidence |
This family
| US 9,744,234 | In force May 2033 | May 2033 |
| US 10,363,307 | In force Oct 2031 | Oct 2031 |
| Application 16/439,423 | Abandoned not computed | not computed |
| US 11,534,491 | In force Mar 2032 | Mar 2032 |
| Application 17/127,758 | Abandoned not computed | not computed |
| Application 17/165,729 | Abandoned not computed | not computed |
| US 12,465,635 | this patent Oct 2031 | Oct 2031 |
| Application 18/048,797 | Abandoned not computed | not computed |
8 of 12 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 14, 2022 Reel 58999, frame 640 | Richards, Hanno | Novartis AG | Assignment of Assignor's Interest |
| Feb 14, 2022 Reel 58999, frame 930 | Thangavelu, Karthinathan | Novartis AG | Assignment of Assignor's Interest |
| Feb 14, 2022 Reel 59000, frame 770 | Machacek, Matthias | Novartis Pharma AG | Assignment of Assignor's Interest |
| Feb 14, 2022 Reel 59000, frame 951 | Novartis Pharma AG | Novartis AG | Assignment of Assignor's Interest |
| Feb 14, 2022 Reel 59100, frame 781 | Mpofu, Shephard | Novartis AG | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Oct 2031
Term ends Oct 28, 2031. Maintenance fees still fall due before then
Note
The 756 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,363,307, US 11,534,491, US 9,744,234.
Citations
0
later US patents cite this one
Fewer than half of the utility patents granted in 2025 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.